- Home
- IONR vs INMB Comparison
IONR vs INMB Comparison
Compare IONR & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IONR
- INMB
- Stock Information
- Founded
- IONR 2001
- INMB 2015
- Country
- IONR Australia
- INMB United States
- Employees
- IONR N/A
- INMB N/A
- Industry
- IONR
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- IONR
- INMB Health Care
- Exchange
- IONR Nasdaq
- INMB Nasdaq
- Market Cap
- IONR 171.1M
- INMB 137.5M
- IPO Year
- IONR N/A
- INMB 2019
- Fundamental
- Price
- IONR $3.94
- INMB $5.88
- Analyst Decision
- IONR
- INMB Buy
- Analyst Count
- IONR 0
- INMB 1
- Target Price
- IONR N/A
- INMB $22.00
- AVG Volume (30 Days)
- IONR 7.2K
- INMB 166.7K
- Earning Date
- IONR 01-01-0001
- INMB 10-30-2024
- Dividend Yield
- IONR N/A
- INMB N/A
- EPS Growth
- IONR N/A
- INMB N/A
- EPS
- IONR N/A
- INMB N/A
- Revenue
- IONR N/A
- INMB $85,000.00
- Revenue This Year
- IONR N/A
- INMB N/A
- Revenue Next Year
- IONR N/A
- INMB N/A
- P/E Ratio
- IONR N/A
- INMB N/A
- Revenue Growth
- IONR N/A
- INMB N/A
- 52 Week Low
- IONR $2.90
- INMB $5.80
- 52 Week High
- IONR $6.50
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- IONR 52.29
- INMB 31.84
- Support Level
- IONR $4.06
- INMB $5.98
- Resistance Level
- IONR $4.62
- INMB $7.04
- Average True Range (ATR)
- IONR 0.25
- INMB 0.40
- MACD
- IONR 0.06
- INMB -0.05
- Stochastic Oscillator
- IONR 46.63
- INMB 5.09
About IONR ioneer Ltd
Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S. based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.